Sudeep Pharma IPO...
19 Nov, 2025
Indegene Limited IPO
Indegene Ltd. (IL) is providing digital-led commercialization services for the life sciences industry, including biopharmaceutical, emerging biotech and medical devices companies, that assist them with drug development and clinical trials, regulatory submissions, pharmacovigilance and complaints management, and the sales and marketing of their products. Its solutions enable life sciences companies to develop products, launch them in the market, and drive sales through their life cycle in a more effective, efficient and modern manner. Indegene IPO is a book built issue of Rs 1,841.76 crores.
The issue is a combination of fresh issue of 1.68 crore shares aggregating to Rs 760.00 crores and offer for sale of 2.39 crore shares aggregating to Rs 1,081.76 crores. Indegene IPO price band is set at ₹430 to ₹452 per share. The minimum lot size for an application is 33 Shares. Kotak Mahindra Capital Company Limited, Citigroup Global Markets India Private Limited, J.P. Morgan India Private Limited and Nomura Financial Advisory And Securities (India) Pvt Ltd are the book running lead managers of the Indegene IPO, while Link Intime India Private Ltd is the registrar for the issue.
WHAT IS GMP?
GMP (Grey Market Premium) is the difference between the IPO price and the grey market price. It is the premium amount paid for the traded IPO shares. It plays an important role in IPOs as it reflects how the IPO would react on the listing day.
A grey market is a place where shares/stocks are traded before being listed officially on the stock exchange.
Indegene Limited IPO
| GMP Date | IPO Price | GMP | Last Updated |
|---|---|---|---|
| - | - | - | - |
**The GMP prices displayed here are solely for informational purposes related to the grey market news. India IPO does not engage in or facilitate grey market trading, nor are these rates (sub2) indicative of any trading activity. We also do not recommend or endorse participation in the grey market.**
Indegene Limited IPO Details
| Detail | Description |
|---|---|
| IPO Date | May 6, 2024 to May 8, 2024 |
| Listing Date | - |
| Face Value | ₹2 per share |
| Price Band | ₹430 to ₹452 per share |
| Lot Size | 33 Shares |
| Total Issue Size | 40,746,891 shares (aggregating up to ₹1,841.76 Cr) |
| Fresh Issue | 16,814,159 shares (aggregating up to ₹760.00 Cr) |
| Offer for Sale | 23,932,732 shares of ₹2 (aggregating up to ₹1,081.76 Cr) |
| Employee Discount | Rs 30 per share |
| Issue Type | Book Built Issue IPO |
| Listing At | BSE, NSE |
| Share holding pre issue | 222,435,091 |
| Share holding post issue | 239,249,250 |
Indegene Limited IPO Timeline
| Detail | Description |
|---|---|
| IPO Open Date | Monday, May 6, 2024 |
| IPO Close Date | Wednesday, May 8, 2024 |
| Basis of Allotment | Thursday, May 9, 2024 |
| Initiation of Refunds | Friday, May 10, 2024 |
| Credit of Shares to Demat | Friday, May 10, 2024 |
| Listing Date | Monday, May 13, 2024 |
| Cut-off time for UPI mandate confirmation | 5 PM on May 8, 2024 |
Indegene Limited IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 33 | ₹14,916 |
| Retail (Max) | 13 | 429 | ₹193,908 |
| S-HNI (Min) | 14 | 462 | ₹208,824 |
| S-HNI (Max) | 67 | 2,211 | ₹999,372 |
| B-HNI (Min) | 68 | 2,244 | ₹1,014,288 |
Indegene Limited IPO Promoter Holding
| Share Holding Pre Issue | Share Holding Post Issue |
|---|---|
| Share Holding Pre Issue | 30.71% |
| Share Holding Post Issue | - |
Competitive Strength:
- -
Indegene Limited IPO Financial Information
| Period Ended | Assets | Revenue | Profit After Tax | Net Worth | Total Borrowing | |||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 31 Dec 2023 | 2,518.15 | 1,969.75 | 241.90 | 1,327.00 | 399.33 | |||||||||||||||||||||||||||||||||||
| 31 Mar 2023 | 2,203.87 | 2,364.10 | 266.10 | 1,063.72 | 394.34 | |||||||||||||||||||||||||||||||||||
| 31 Mar 2022 | 1,353.47 | 1,690.50 | 162.82 | 763.90 | 18.24 | |||||||||||||||||||||||||||||||||||
| 31 Mar 2021 | 596.04 | 996.92 | 149.41 | 324.51 | 24.76 | |||||||||||||||||||||||||||||||||||
| Amount in ₹ Crore | ||||||||||||||||||||||||||||||||||||||||
Key Performance Indicator
| KPI | Values |
|---|---|
| Debt/Equity | 0.3 |
| RoNW | 18.23% |
| P/BV | 7.55 |
| PAT Margin (%) | 12.62 |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (Rs) | 11.96 | 13.48 |
| P/E (x) | 37.78 | 33.53 |
Objectives of Indegene IPO
The Company proposes to utilise the Net Proceeds towards funding the following objectives:-
- 1. Repayment/prepayment of indebtedness of one of the Material Subsidiaries, ILSL Holdings.
- 2. Funding the capital expenditure requirements of the Company and one of the Material Subsidiaries, Indegene.
- 3. General corporate purposes and inorganic growth.
Indegene IPO Review
The company has a unique business model and enjoys virtual monopoly in its business that generates over 98% global revenue. It marked steady growth in its top and bottom lines for the reported periods, and the segment is poised for bright prospects ahead. Based on FY24 annualized earnings, the issue appears fully priced, but considering its niche play, it is reasonably priced leaving something on table for one and all. Investors may lap up this IPO for the medium to long term rewards.
RHP:
DRHP:
Read more :
Frequently asked Questions (FAQs )
-
What Is The Size Of The Indegene Limited IPO?
The offer size of Indegene Limited is INR 1,841.76 crores, consisting of a fresh issue of shares worth INR 760 crores and an offer to sell 1,081.76 crore shares. The company aims to manage debt, finance projects, and pursue growth opportunities for sustainable development.
-
What Is The Price Band Of The Indegene Limited IPO?
The price band of the issue is INR 430-452 per share.
-
When will Indegene IPO open for subscription?
The IPO subscription window will open on May 6, 2024.
-
What is the listing date of the Indegene Limited IPO?
The listing date of Indegene Limited’s IPO is May 13, 2024.
.jpg)
